NCT06296017 Effectiveness of Conservative Interventions in the Treatment of Trigger Finger
| NCT ID | NCT06296017 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | Trigger Finger |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2023-10-02 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2023-10-02 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
There is no study in the literature comparing the effectiveness of ESWT and splint therapy, which are the most commonly used approaches in the treatment of Trigger Finger (TF). The aim in this study is to investigate the effectiveness of ESWT and splint therapy used in the treatment of TF.
Eligibility Criteria
Inclusion Criteria: * Volunteering * Being between the ages of 18-65 * Being diagnosed with stage 1 or stage 2 (according to the Froimson classification) trigger finger * Having the language and cognitive skills to answer the questionnaires used in the evaluation Exclusion Criteria: * Being pregnant * Having an inflammatory disorder * Having had surgery on the hand/wrist * Having a neurological disease * NSAIDs, painkillers, etc. being on medication * De Quervain's tenosynovitis, carpal tunnel syndrome
Contact & Investigator
Kadir ÇEVİK
STUDY DIRECTOR
Etlik Şehir Hastanesi
Frequently Asked Questions
Who can join the NCT06296017 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Trigger Finger. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06296017 currently recruiting?
Yes, NCT06296017 is actively recruiting participants. Contact the research team at karademirferay@gmail.com for enrollment information.
Where is the NCT06296017 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06296017 clinical trial?
NCT06296017 is sponsored by Hacettepe University. The principal investigator is Kadir ÇEVİK at Etlik Şehir Hastanesi. The trial plans to enroll 54 participants.